Using Tolvaptan to Treat Hyponatremia: Results from a Post-authorization Pharmacovigilance Study

INTRODUCTION: Hyponatremia is a common condition of varying etiology among hospitalized patients and is associated with adverse outcomes. Treatment to normalize serum sodium is advisable. Tolvaptan received European Union marketing authorization for hyponatremia secondary to the syndrome of inapprop...

Descripción completa

Detalles Bibliográficos
Autores principales: Estilo, Alvin, McCormick, Linda, Rahman, Mirza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8572184/
https://www.ncbi.nlm.nih.gov/pubmed/34693505
http://dx.doi.org/10.1007/s12325-021-01947-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8572184/
https://www.ncbi.nlm.nih.gov/pubmed/34693505
http://dx.doi.org/10.1007/s12325-021-01947-9

Ejemplares similares